Interrelationships among measures of premature ejaculation: The central role of perceived control

Journal of Sexual Medicine

Volumn 4, Issue 3, 2007, Pages 780-788

  Patrick, Donald L ^a   Rowland, David ^b   Rothman, Margaret ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VALPARAISO UNIVERSITY   (United States)

^c JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Distress; Interpersonal difficulty; Intravaginal ejaculatory latency time; Perceived control over ejaculation; Premature ejaculation

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; BIVARIATE ANALYSIS; CORRELATION COEFFICIENT; HUMAN; INTERPERSONAL STRESS; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERCEPTIVE THRESHOLD; PREMATURE EJACULATION; PRIORITY JOURNAL; REGRESSION ANALYSIS; SEXUAL INTERCOURSE; SEXUAL SATISFACTION; UNITED STATES;

EID: 34249110975     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2007.00464.x     Document Type: Article

References (23)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, DSM-IV. 4th edition, text rev. Washington, DC: American Psychiatric Association; 2000.
2. McMahon CG, Abdo C, Incrocci L, Perelman M, Rowland D, Waldinger M, Xin Z. Disorders of orgasm and ejaculation in men. J Sex Med 2004;1:58-65.
3. Montague DK, Jarow J, Broderick G, Dmochowski RR, Heaton JP, Lue TF, Nehra A, Sharlip ID, AUA Erectile Dysfunction Guideline Update Panel. AUA guideline on the pharmacologic management of premature ejaculation. J Urol 2004;172:290-4.
4. National Center for Health Statistics. International classification of diseases. Ninth revision, clinical modifications (ICD-9-CM). Available at: http://www.cdc.gov/nchs/about/otheract/icd9/abticd9.htm (accessed December 7, 2005).
5. Waldinger MD, Schweitzer DH. Changing paradigms from a historical DSM-III and DSM-IV view toward an evidence-based definition of premature ejaculation. Part I-Validity of DSM-IV-TR. J Sex Med 2006; 3: 682-92.
6. Waldinger MD, Schweitzer DH. Changing paradigms from a historical DSM-III and DSM-IV view toward an evidence-based definition of premature ejaculation. Part II - Proposals for DSM-V and ICD-11. J Sex Med 2006; 3: 693-705.
7. Patrick DL, Althof SE, Pryor JL, Rosen R, Rowland DL, Ho KF, McNulty P, Rothman M, Jamieson C. Premature ejaculation: An observational study of men and their partners. J Sex Med 2005; 2: 358-67.
8. Rosen RC, McMahon CG, Niederberger C, Broderick GA, Jamieson C, Gagnon DD. Correlates to the clinical diagnosis of premature ejaculation: Results from a large observational study of men and their partners. J Urol 2007; 177: 1059-64.
9. Jannini EA, Lenzi A. Epidemiology of premature ejaculation. Curr Opin Urol 2005; 15: 399-403.
10. Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B. Effect of SSRI antidepressants on ejacu-lation: A double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. J Clin Psychopharmacol 1998; 18: 274-81.
11. Pryor JL, Althof SE, Steidle C, Rosen RC, Hellstrom WJG, Shabsigh R, Miloslavsky M, Kell S, for the Dapoxetine Study Group. Efficacy and tolerability of dapoxetine in the treatment of premature ejaculation: Integrated analysis of two randomized, double-blind, placebo-controlled trials. Lancet 2006; 368: 929-37.
12. Rowland DL. Treatment of premature ejaculation: Selecting outcomes to determine efficacy. Bull Int Soc Sex Impot Res 2003; 32: 261-70.
13. McMahon C. The etiology and management of premature ejaculation. Nat Clin Pract Urol 2005; 2: 426-33.
14. US FDA, Center for Drug Evaluation and Research. Guidance for industry: Patient-reported outcome measures: Use in medical product development to support labeling claims. Rockville, MD: US FDA, Center for Drug Evaluation and Research; 2006.
15. Giuliano F, Niederberger CS, Rosen RC, Patrick DL, Ho KF, Jamieson C, Gagnon DD. Identification of key criteria for distinguishing between subjects with and without premature ejaculation (PE) in clinical trials [abstract]. J Sex Med 2006; 3: 28-9.
16. Rowland DL, Cooper SE, Schneider M. Defining premature ejaculation for experimental and clinical investigations. Arch Sex Behav 2001;30:235-53.
17. Bryne BM. A primer of LISREL. Basic applications for programming for confirmatory factor analytic models. New York: Springer Verlag; 1989.
18. Kline RB. Principles and practice of structural equation modeling. 2nd edition. New York: The Guilford Press; 2005.
19. Browne MW, Cudeck R. Alternative ways of assessing model fit. In: Bollen KA, Long JS, eds. Testing structural equation models. Newbury Park, CA: Sage; 1993:136-62.
20. McMahon CG, Abdo C, Hull E, Incrocci L, Levin R, Perelman M, Rowland D, Sipski M, Stuckey B, Waldinger M, Cheng Xin Z. Disorders of orgasm and ejaculation in men. In: Lue TF, Basson R, Rosen R, Giuliano F, Khoury S, Montorsi F, eds. Sexual medicine: Sexual dysfunctions in men and women. Paris: Health Publications; 2004: 409-68.
21. Wang W, Kumar P, Minhas S, Ralph D. Proposals or findings for a new approach about how to define and diagnose premature ejaculation. Eur Urol 2005; 48: 418-23.
22. Symonds T, Roblin D, Hart K, Althof S. How does premature ejaculation impact a man's life? J Sex Marital Ther 2003; 29: 361-70.
23. Kaplan HS. Premature ejaculation: How to overcome premature ejaculation. New York: Brunner/Mazel; 1989.